Retatrutide is not listed in Chia’s current treatment catalog, so we do not offer it for online prescribing. Patients searching for retatrutide should know the difference between research-use-only peptides and prescribed medications. Chia does offer clinician-reviewed online access to tirzepatide and semaglutide when clinically appropriate.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you order retatrutide online in the United States?
For patients, the practical answer is no: retatrutide is not an FDA-approved prescription medication and is not something Chia offers online. Retatrutide appears in clinical trials and on some research-use peptide sites, but those are not the same as a legal, clinician-reviewed prescription pathway 1 3 4.
What patients usually mean by “order online”
Most people typing “order retatrutide online” are asking one of three things: whether a licensed clinician can prescribe it, whether a pharmacy can dispense it, or whether a peptide website can ship it. Those are very different questions. FDA approval, a valid prescription, and pharmacy dispensing are medical and legal steps; a research-use website listing is not medical care 4 5.
Why research-use peptide websites are different from medical prescribing
A research-use-only peptide is usually labeled for laboratory use, not for human treatment. That means there may be no clinician screening, no medication history review, no prescription, and no ongoing follow-up. FDA warns patients to be careful with online drug sellers that do not require a prescription or a licensed health professional’s review 5.
What to verify before considering any medication sold online
- Does the process include a real health history and licensed clinician review?
- Is a prescription required when the medication requires one?
- Is the prescription not guaranteed?
- Is the dispensing pharmacy identified and appropriately licensed?
- Are side effects, contraindications, and follow-up clearly explained?
- Is the site avoiding research-use chemicals for human use?
Is retatrutide FDA-approved or available as a prescription?
Retatrutide is investigational. FDA’s public drug approval database should be the source patients use to confirm whether a drug has an approved application, and retatrutide is not an FDA-approved prescription product for routine prescribing 4.
Retatrutide is being studied in human trials. In a phase 2 obesity trial, Jastreboff and colleagues studied once-weekly retatrutide doses of 1 mg, 4 mg, 8 mg, and 12 mg; at 48 weeks, mean weight change ranged from 8.7% to 24.2% depending on the study group, while gastrointestinal side effects were common and heart rate increased in a dose-related way 1. Individual results vary, and study results do not make an investigational drug available for general prescribing.
What availability means
Availability can mean several things: an FDA-approved label, an active clinical trial, a sponsor’s research supply, a prescription product, or a compounded preparation. Those categories are not interchangeable. Retatrutide is being studied in clinical trials, including obesity trials listed on ClinicalTrials.gov, but trial enrollment is not the same as online prescribing 3.
Why “available online” can be misleading
A website can list a product without that product being an approved medication or a legally prescribed treatment. FDA’s BeSafeRx program warns that unsafe online pharmacies may sell products without valid prescriptions, ship drugs with unknown ingredients, or provide products that are too strong, too weak, expired, contaminated, or otherwise unsafe 5.
What is retatrutide, and how is it different from GLP-1 medications?
Retatrutide, also called LY3437943, is a triple incretin receptor agonist. In plain English, it is designed to act on three hormone receptor pathways discussed in metabolism research: the GLP-1 receptor, GIP receptor, and glucagon receptor 1 2.
GLP-1 receptor activity is linked with appetite, stomach emptying, and glucose regulation. GIP receptor activity is involved in insulin and metabolic signaling. Glucagon receptor activity affects liver glucose output and energy balance. Retatrutide’s research question is whether acting on all three pathways may affect weight and metabolic markers, but mechanism alone does not prove long-term safety or real-world access 1 2.
This is different from semaglutide and tirzepatide. Semaglutide is a GLP-1 receptor agonist; brand examples include Wegovy, Ozempic, and Rybelsus. Tirzepatide is a dual GIP/GLP-1 receptor agonist; brand examples include Zepbound and Mounjaro 7 8 9.
What are the risks of buying retatrutide from a peptide website?
The main risk is that a research-use-only peptide may look like a medication online, but it may not come with the safeguards of medical care. Those safeguards include eligibility screening, prescription review, pharmacy standards, side effect planning, and follow-up 5 6.
Research-use-only labeling and what it means
Research-use-only labeling generally means the product is being sold for laboratory or analytical use, not for human treatment. A peptide site may mention purity, testing, or a certificate of analysis, but those documents do not replace a medical diagnosis, a prescription, or pharmacy dispensing under a clinician’s care 5.
Identity, sterility, dosing, and contamination concerns
With any injectable product, identity, strength, sterility, storage, and contamination matter. FDA notes that compounded drugs are not FDA-approved and do not go through FDA premarket review for safety, effectiveness, or quality; that makes the source and clinical oversight especially important when compounded medication is used 6. For non-prescription research chemicals, the medical oversight gap can be even larger.
Why a certificate of analysis is not the same as a prescription
A certificate of analysis may describe one lab’s testing for a sample or lot. It does not tell a clinician whether the product is right for your health history, whether your symptoms could come from another condition, how to manage side effects, or whether the source is legally dispensing medication for human use 5.
Retatrutide vs tirzepatide: what is the practical difference for patients today?
The practical difference is access. Tirzepatide has FDA-approved brand products for specific labeled uses, while retatrutide remains investigational and is not available for routine prescribing 3 7 9.
| Medication | Drug class | FDA-approved brand examples | Prescription access today | Chia availability |
|---|---|---|---|---|
| Retatrutide / LY3437943 | Investigational triple incretin receptor agonist: GLP-1, GIP, and glucagon receptor activity | None | Clinical trials only; not routine prescribing | Not offered by Chia |
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | Zepbound for chronic weight management in certain adults; Mounjaro for type 2 diabetes | Prescription required; eligibility and contraindications must be reviewed | Chia offers compounded tirzepatide tablets and injections through licensed-provider review |
| Semaglutide | GLP-1 receptor agonist | Wegovy for chronic weight management in certain patients; Ozempic and Rybelsus for type 2 diabetes | Prescription required; eligibility and contraindications must be reviewed | Chia offers compounded semaglutide injections through licensed-provider review |
No one should treat this table as a claim that one option is best for every person. Retatrutide phase 2 studies are promising but still investigational, and reported benefits came with side effects such as nausea, diarrhea, vomiting, constipation, and increased heart rate 1. Tirzepatide and semaglutide also carry gastrointestinal side effects and important warnings on their FDA-approved labels 7 8.
Does Chia offer retatrutide online?
No. Chia does not currently offer retatrutide, and we do not describe it as something patients can buy, compound, or receive through our clinic.
What we can offer is a licensed-provider evaluation for treatments that are in our current catalog. For weight-management care, Chia offers tirzepatide tablets and injections, with microdosing plans available when clinically appropriate, and semaglutide injections, also with microdosing plans available when clinically appropriate. A prescription is never guaranteed.
Here is how Chia works: you complete a short online health questionnaire, a licensed US provider reviews your eligibility, and medication is prescribed only when clinically appropriate. If prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Patients can message their care team through the portal between visits.
| Chia option | Forms Chia offers | Current starting price | Notes |
|---|---|---|---|
| Tirzepatide | Tablets and injection | Tablets from $249/mo; injection from $299/mo | Microdosing plans available; prescription requires licensed-provider review |
| Semaglutide | Injection | From $249/mo | Microdosing plans available; prescription requires licensed-provider review |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/mo | May be relevant when energy goals are part of the clinical discussion |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/mo | May be relevant when body-composition goals are part of the clinical discussion |
If you want to understand the online prescription process before starting, our guide to ordering GLP-1 medication online safely explains the steps to look for. You can also start with Chia’s eligibility quiz if you want a licensed provider to review whether an offered treatment may fit your goals.
What legal online alternatives may be available through clinician review?
For many patients asking about retatrutide, the safer practical question is whether a clinician-reviewed GLP-1 or incretin-based treatment is appropriate today. Compounded tirzepatide via a 503A pharmacy and compounded semaglutide via a 503A pharmacy may be options through Chia when a licensed provider decides they are clinically appropriate.
Compounded tirzepatide through a licensed provider
Tirzepatide is the active ingredient in FDA-approved brand medications with labeled uses for chronic weight management and type 2 diabetes, depending on the product 7 9. Chia’s compounded tirzepatide is not FDA-approved and does not have FDA-evaluated outcomes data; our role is to provide clinician review, provider-guided dosing, 503A pharmacy dispensing, and follow-up when appropriate.
Compounded semaglutide through a licensed provider
Semaglutide is the active ingredient in FDA-approved brand medications with labeled uses for chronic weight management and type 2 diabetes, depending on the product 8 10. Chia’s compounded semaglutide is not FDA-approved and does not have FDA-evaluated outcomes data; it is available only after a licensed-provider review and prescription when appropriate.
When Weight + Energy or Weight + Muscle may be relevant at Chia
Some patients want weight care plus support for energy or body-composition goals. Chia’s Weight + Energy protocol includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle includes sermorelin injection plus a choice of GLP-1. These protocols still require medical review, and they are not substitutes for nutrition, movement, sleep, and follow-up.
How can you tell whether an online medication source is legitimate?
A legitimate online medication path should feel like medical care, not a cart checkout. At minimum, it should include clinician review and should not guarantee a prescription before your health history is reviewed 5.
- 1Look for a health history intake that asks about diagnoses, medications, allergies, pregnancy status, past side effects, and relevant symptoms.
- 2Confirm that a licensed clinician reviews the request and can say no when treatment is not appropriate.
- 3Avoid sites that sell prescription-type products without a prescription.
- 4For compounded medication, look for dispensing through a state-licensed 503A compounding pharmacy.
- 5Read the safety information, including common side effects and serious warnings.
- 6Make sure follow-up is available for side effects, dose adjustments, and questions.
- 7Do not treat research-use-only peptides as medications for human use.
If your real goal is weight-management treatment, it may help to read our guide on whether you can get weight-loss medication online. If your goal is specifically tirzepatide, our article on ordering tirzepatide online explains prescription-only access in more detail.
What should you do if you were planning to buy retatrutide online?
Pause before buying. Retatrutide is not available as a routine prescription, and a research-use listing should not be treated as medical treatment 3 4.
A safer next step is to speak with a licensed clinician about your goals, health history, and available options. That conversation can cover obesity, overweight with weight-related conditions, type 2 diabetes, medication interactions, pancreatitis history, gallbladder disease, pregnancy plans, and side effect tolerance. These details matter for GLP-1 and incretin-based medications 7 8 9.
You may see retatrutide listed on research-use peptide websites, but that is not the same as buying a prescribed medication. Retatrutide is investigational, not FDA-approved, and Chia does not offer it.
Retatrutide is available in the context of clinical research, not as a routine prescription medication. Clinical trial access depends on trial enrollment criteria and study sites.
No. Retatrutide is not FDA-approved for obesity, overweight, type 2 diabetes, or any other routine prescription use.
For prescription-type treatment, the safer question is whether the process includes a licensed clinician, a real health history review, a valid prescription when required, and an appropriately licensed pharmacy. A research-use peptide website is not the same as medical care.
There is not enough evidence to say retatrutide is better for patients today. Retatrutide is still investigational, while tirzepatide has FDA-approved brand products for specific labeled uses. Any comparison should be handled by a clinician.
No. Chia does not currently offer or prescribe retatrutide.
Chia offers online clinician review for compounded tirzepatide tablets and injections, and compounded semaglutide injections. A licensed US provider must review your eligibility and prescribe only when clinically appropriate. A prescription is never guaranteed.
No. Compounded medications are not FDA-approved, and FDA does not evaluate compounded formulations for safety, effectiveness, or quality before they are dispensed.
References
- 1.Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine. 2023.
- 2.Rosenstock J, Frias JP, Rodbard HW, et al. Retatrutide for the treatment of type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial. The Lancet. 2023.
- 3.ClinicalTrials.gov. A Study of Retatrutide (LY3437943) in Participants With Obesity and Overweight (TRIUMPH-1), NCT05929066. 2026.
- 4.U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs database. 2026.
- 5.U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. 2026.
- 6.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2026.
- 7.U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. 2025.
- 8.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2024.
- 9.U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. 2024.
- 10.U.S. Food and Drug Administration. Ozempic (semaglutide) Prescribing Information. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



